Literature DB >> 27717259

Mindfulness-based cognitive therapy for relapse prophylaxis in mood disorders.

Zindel V Segal1, Le-Anh Dinh-Williams1.   

Abstract

Entities:  

Year:  2016        PMID： 27717259      PMCID： PMC5032518          DOI： 10.1002/wps.20352

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  9 in total

1.  Cognitive reactivity to sad mood provocation and the prediction of depressive relapse.

Authors:  Zindel V Segal; Sidney Kennedy; Michael Gemar; Karyn Hood; Rebecca Pedersen; Tom Buis
Journal:  Arch Gen Psychiatry       Date:  2006-07

Review 2.  A systematic review of mechanisms of change in mindfulness-based cognitive therapy in the treatment of recurrent major depressive disorder.

Authors:  Anne Maj van der Velden; Willem Kuyken; Ulla Wattar; Catherine Crane; Karen Johanne Pallesen; Jesper Dahlgaard; Lone Overby Fjorback; Jacob Piet
Journal:  Clin Psychol Rev       Date:  2015-02-11

3.  Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians.

Authors:  G E Simon; M Von Korff; C M Rutter; D A Peterson
Journal:  Arch Gen Psychiatry       Date:  2001-04

Review 4.  The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis.

Authors:  Jacob Piet; Esben Hougaard
Journal:  Clin Psychol Rev       Date:  2011-05-15

5.  Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.

Authors:  Zindel V Segal; Peter Bieling; Trevor Young; Glenda MacQueen; Robert Cooke; Lawrence Martin; Richard Bloch; Robert D Levitan
Journal:  Arch Gen Psychiatry       Date:  2010-12

6.  Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.

Authors:  J D Teasdale; Z V Segal; J M Williams; V A Ridgeway; J M Soulsby; M A Lau
Journal:  J Consult Clin Psychol       Date:  2000-08

7.  Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial.

Authors:  Willem Kuyken; Rachel Hayes; Barbara Barrett; Richard Byng; Tim Dalgleish; David Kessler; Glyn Lewis; Edward Watkins; Claire Brejcha; Jessica Cardy; Aaron Causley; Suzanne Cowderoy; Alison Evans; Felix Gradinger; Surinder Kaur; Paul Lanham; Nicola Morant; Jonathan Richards; Pooja Shah; Harry Sutton; Rachael Vicary; Alice Weaver; Jenny Wilks; Matthew Williams; Rod S Taylor; Sarah Byford
Journal:  Lancet       Date:  2015-04-20       Impact factor: 79.321

8.  Web-based intervention in mindfulness meditation for reducing residual depressive symptoms and relapse prophylaxis: a qualitative study.

Authors:  Jennifer M Boggs; Arne Beck; Jennifer N Felder; Sona Dimidjian; Christina A Metcalf; Zindel V Segal
Journal:  J Med Internet Res       Date:  2014-03-24       Impact factor: 5.428

9.  The effects of amount of home meditation practice in Mindfulness Based Cognitive Therapy on hazard of relapse to depression in the Staying Well after Depression Trial.

Authors:  Catherine Crane; Rebecca S Crane; Catrin Eames; Melanie J V Fennell; Sarah Silverton; J Mark G Williams; Thorsten Barnhofer
Journal:  Behav Res Ther       Date:  2014-08-30
  9 in total
  3 in total

1.  Mindfulness-based cognitive therapy for the treatment of current depressive symptoms: a meta-analysis.

Authors:  Simon B Goldberg; Raymond P Tucker; Preston A Greene; Richard J Davidson; David J Kearney; Tracy L Simpson
Journal:  Cogn Behav Ther       Date:  2019-02-08

Review 2.  Unfolding the Role of BDNF as a Biomarker for Treatment of Depression.

Authors:  Tarapati Rana; Tapan Behl; Aayush Sehgal; Pranay Srivastava; Simona Bungau
Journal:  J Mol Neurosci       Date:  2020-11-23       Impact factor: 3.444

Review 3.  Mindfulness-based cognitive therapy for residual depressive symptoms and relapse prophylaxis.

Authors:  Zindel V Segal; Kathleen M Walsh
Journal:  Curr Opin Psychiatry       Date:  2016-01       Impact factor: 4.741
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.